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Primary lymphoma of the liver is an extremely rare entity. A case of anaplastic large B-cell (both CD-20 and lambda
positive) non-Hodgkin’s lymphoma that was confined to the liver in a 33-year-old man is reported. The patient was treated
with an extended right hepatectomy and combination chemotherapy: cyclophosphamide, adriamycin, vincristine, and
prednisone.
The patient was disease free 24 months after the procedure.
DESCRIPTORS:  Liver lymphoma.  Surgery.  Chemotherapy.
Primary lymphomas of the liver are
notably rare1,2, and as a result in the
past, and even quite recently, they
have been diagnosed only at postmor-
tem examination3-5.
About 70 patients with this disease
have been described in the past 40
years in the literature, but only 16 pa-
tients, including our case, have been
treated surgically so far.
The predominant histologic de-
scription of these lesions includes B-
cell lymphomas of the so-called histio-
cytic type5-7 or the larged differentiated
cell6,8. Other variants reported include
the lymphocytic type3,9-11, reticulum
cell sarcoma12, undifferentiated non-
Hodgkin’s lymphoma4, and
centroblastic-centrocytic lymphoma13.
We report a case of a patient with
primary malignant lymphoma of the
liver, of B-cell origin, who underwent
surgical treatment followed by sys-
temic chemotherapy.
CASE REPORT
A 33-year-old white man was re-
ferred for evaluation of an epigastric
mass first noted 3 months previously.
Associated with the mass were leth-
argy, anorexia, and a 6.5 kg weight
loss. The patient denied experiencing
fevers, chills, night sweats, nausea, or
vomiting. The past medical history
was benign, and the patient was on no
medications. The physical examina-
tion revealed a large palpable, smooth,
nontender mass in the right hypochon-
drium that extended from the costal
arch to the umbilicus. The spleen was
not palpable, and there were no other
abdominal masses. There was no lym-
phadenopathy. The remainder of the
examination was normal.
Laboratory studies showed the fol-
lowing: serum glutamic oxaloacetic
transaminase (SGOT) 32 IU/L, lactic
dehydrogenase 1190 IU/L, bilirubin
direct 0.4 mg/dL, bilirubin indirect 0.1
mg/dL, albumin 3.9 g/dL, prothrombin
time 100%, alpha-fetoprotein 16.8 ng/
dL, and carcinoembryonic antigen 1.7
ug/L, (Table 1). The other laboratory
results were normal.
A computed tomography (CT) scan
of the abdomen disclosed a large mass
replacing the right lobe of the liver
with no other abdominal masses or ad-
enopathy. A chest CT scan was normal.
Nuclear magnetic resonance study
showed that the mass did not extend
into the vena cava or the portal vein
(Fig. 1). An arteriogram revealed nor-
mal hepatic arterial anatomy. A bone
scan was negative for metastases.
Because of the favorable anatomic
3097.p65 30/10/02, 10:45223
224
REV. HOSP. CLÍN. FAC. MED. S. PAULO 57(5):223-228, 2002 SEPTEMBER-OCTOBER
location of the tumor and the absence
of metastatic disease, an extended
right hepatectomy was performed. The
resection included the entire right
lobe plus segment IVa and IVb. Both
the right and middle hepatic veins
were taken, leaving about 1 cm of liver
tissue adjacent to the left hepatic vein.
The abdominal exploration revealed
no evidence of extrahepatic tumor or
adenopathy.
After the final pathologic diagno-
sis, bone marrow and cerebral spinal
fluid were examined and found to be
free of disease. The patient had mild
ascites and right pleural effusion that
required pleural punctation because of
restrictive pulmonary insufficiency. He
was discharged from the hospital on
the 14th postoperative day.
Postoperatively, the patient re-
ceived systemic chemotherapy of cy-
clophosphamide, adriamycin, vincris-
tine and prednisone. Twenty-four
months after surgery, the patient con-
tinues to be free of disease.
PATHOLOGIC  STUDY
The surgical specimen consisted of
a right hepatic lobe plus segment IV,
weighing 3340 g, and containing a
neoplasm of 18 cm x 15.5 cm x 10 cm.
The tumor appeared grayish white,
soft, and homogenous, with focal
hemorrhage and necrosis. Its border
was well circumscribed and lobulated,
and appeared to be completely within
the limits of resection (Fig. 2).
Microscopically, the liver was
composed of an infiltrative diffuse
lymphoreticular neoplasia. There was
a uniform population of lymphoid
cells of large size with many mitotic
figures (Fig. 3). The large neoplastic
lymphoid cells immunostained posi-
tively for leukocyte common antigen
and for B-cell markers including CD-
20. CD-45RO–marked lymphocytes
and CD-68–marked macrophages were
present within the neoplasm.
The tumor was a large, lambda posi-
tive, CD-20 positive, anaplastic malig-
nant B-cell lymphoma. Tests for CD-34,
carcinoembryonic antigen, cytokeratin
7, alpha-protein, neurospecific actin,
and enolase were negative.
DISCUSSION
The first report of primary hepatic
lymphoma was by Ata and Kamal in
196514. Primary hepatic lymphoma has
been reported in 48 patients15-20. Only
2 of these previously reported cases
have been children16.
The review of the literature reveals
that primary lymphoma of the liver oc-
curs in a wide age range (7 to 84 years)
and has been reported mainly in male
patients. The gross involvement of the
liver is of 1 or several nodules, and mi-
croscopically the dominant type is the
large cell histiocytic type15.
The cellular phenotype has been
determined in 13 previous cases: 11 B-
cell and 2 macrophage. None carried
T-cell markers. The phenotype of one
of the previous pediatric lymphomas
was B-cell and the other was not de-
termined.
Table 1 - Laboratory data on admission.
Albumin (4.0-5.0 g/dL) 3.9 g/dL
Serum Glutamate Oxalate Transaminase (7-33 IU/L) 32 IU/L
Serum Glutamate Pyruvate Transaminase (5-30 IU/L) 16 IU/L
Lactic dehydrogenase (260-480 IU/L) 1190 IU/L
Bilirubin direct (0.2-1.1 mg/dL) 0.4 mg/dL
Bilirubin indirect (0-0.3 mg/dL) 0.1 mg/dL
Prothrombin time (>70%) 100%
Alpha-fetoprotein (20 ng/mL) 16.8 ng/mL
Carcinoembryonic antigen (8 mg/L) 1.7 mg/L
Figure 1 - Nuclear magnetic resonance shows a large, low-density solid mass in the right
hepatic lobe of the liver.
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The current case expressed B-cell
but not T-cell or macrophage markers.
The case satisfies the criteria for a pri-
mary hepatic lymphoma as described
by Torres and Bollozos 3,21 and more
recently by Strayer et al.5.
The clinical presentation of pri-
mary lymphoma of the liver has been
fairly uniform — middle-aged patients
presenting with right upper quadrant
or epigastric pain/discomfort in whom
hepatomegaly or a tender mass is pal-
pable.
Concerning hepatic resection, the
perioperative strategies for reducing
morbidity have improved signifi-
cantly over recent years27-29 with a re-
duction of operative mortality to
3.7%30,31.
In our case during surgery, there
was no evidence of extrahepatic in-
volvement, and the spleen was normal.
There was no intra-abdominal aden-
opathy detected. Therefore, we per-
formed an extended right hepatectomy.
The immediate postoperative pe-
riod was uneventful except for both
mild ascites and pleural effusion,
which was treated clinically.
Multi-agent chemotherapy was
started 3 weeks after the surgical pro-
cedure and was completed within 6
months. The patient was disease free
24 months after the treatment.
According to the more recent lit-
erature, treatment of primary hepatic
lymphoma varies. For example, 1 pa-
tient treated with left hepatic lobec-
tomy alone is disease free7. The dis-
ease-free survival rate for 5 patients
treated with resection and chemo-
therapy was 80%15,18. Of 13 patients
treated with chemotherapy alone, 54%
are disease free7,16,20.
Two cases reported by Leahy et al.6
were treated with chemotherapy; 1 pa-
tient had a complete remission and 1
a partial remission.
The importance of surgical resec-
tion in localized disease thereby af-
fording a cure or at least a reduction
of tumor burden cannot be assessed in
this limited series.
Whether or not systemic treatment
with chemotherapy will give compa-
rable results to surgery in resectable
cases is also not currently known. It
seems reasonable to first treat these pa-
tients with systemic chemotherapy. If
disease persists or only partially re-
gresses in the liver, and there is no evi-
dence of extrahepatic involvement,
surgical resection can be performed.
We did not perform surgery in this
case, because of the extent of the dis-
ease, which had spread almost
throughout the whole liver (segments
IV, V, VI, VII, and VIII ).
Many kinds of treatment, such as
chemotherapy, radiation therapy, and
percutaneous ethanol injection
Figure 2 - Cross section of a surgical specimen demonstrate a lobulated tumor (18 cm x 15.5
cm x 10 cm). The tumor is yellowish-white in color and elastically hard in consistency.
Figure 3 - Microscopic findings show a uniform population of lymphoid cells of large size with
many mitotic figures (H&E, original magnification x480).
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therapy, have been reported for pri-
mary malignant lymphoma of the liver.
Previous reports7,8,15,18,22,24-28 of 15 pa-
tients who underwent hepatic resection
are reviewed (Table 2). With the ex-
ception of 3 cases, all cases received
multi-agent chemotherapy postopera-
tively. Fourteen were alive at the time
Table 2. Surgically resected primary malignant lymphoma of the liver in the literature.
No Literature Age, Chief complaint LDH Tumor Size Surgery Adjuvant Prognosis
Sex (IU/L) Location (cm) Therapy (months)
1 Daniel 60, F Fever up ND Bilateral lobes 10x10 Extended lt lobectomy None 22, alive
2 Osborne 48, F RUQ pain 124 ND 4x10 Excised Chemo 124, alive
3 Osborne 58,M Abdominal pain 277 Lt. lobe 11x10 Excised Chemo 20, alive
4 Ryoo 23,M RUQ pain ND Rt. lobe 7x6x4 Rt. Lobectomy none 18, alive
5 Redondo 24 F Epigastric pain ND Lt. lobe ND Lt. Lobectomy Chemo 21, alive
6 Ryan 65,M Epigastric 531 Rt. lobe 30x25 Trisegmentectomy Chemo 61, alive
discomfort
7 Ryan 57,M Lethargy 233 Rt. lobe 11x9x5 Trisegmentectomy Chemo 15, died
8 Ryan 49,M RUQ pain 248 Rt. lobe 10 Trisegmentectomy Chemo+ 61, alive
radiation
9 Ryan 36,M RUQ pain 438 Rt. lobe 15x15 Rt. Lobectomy Chemo 53, alive
1 0 Millis 11,M Abdominal Normal Rt. lobe 19x17x12 Rt. Lobectomy Chemo 30, alive
swelling
11 Andreola 22,M RUQ pain jaundice ND Rt .lobe 10 Trisegmentectomy None 62, alive
12 Pescowitz 17,M Epigastric mass 3770 Lt.lobe+S8 16x14x10 Lt. Lobectomy Chemo 12, alive
S8 partial
13 Hida 45,M Epigastric pain 910 Lt. lateral lobe 15x10x7 Lt. Lateral segmentectomy Chemo 6, alive
14 Mitsui 58,M RUQ pain 202 Lt. lobe 10x7x7 Lt. Lobectomy Chemo 36, alive
15 Taketomi 51,M Free 1180 Rt. lobe 7x6x4 Extended rt. Lobectomy Chemo 45, alive
16 Our case 33,M Lethargy, 1190 Rt. Lobe + S1 26x22x10 Trisegmentectomy Chemo 24, alive
weight loss
ND: not described, LDH: lactic dehydrogenase, RUQ: right upper quadrant, Rt.: right, Lt.: left, Chemo: chemotherapy, M: male, F: female
of their respective case reports, at in-
tervals ranging from 5 to 124 months
(mean 39 months).
Pescovitz et al.24 noted that the dis-
ease-free survival rate for 5 patients
treated with resection and combined
chemotherapy was 80%, compared with
54% survival for chemotherapy alone.
In conclusion, although we do not
deny the effectiveness of chemo-
therapy as shown in some reports7,30,31,
we consider hepatic resection com-
bined with chemotherapy to be the
best method of therapy for this disease
in the absence of any extra-hepatic le-
sions.
3097.p65 30/10/02, 10:45226
227
REV. HOSP. CLÍN. FAC. MED. S. PAULO 57(5):223-228, 2002SEPTEMBER-OCTOBER
RESUMO RHCFAP/3097
CHAIB E e col. – Linfoma primário do
fígado tratado por hepatectomia
ampliada e quimioterapia: relato de
caso. Rev. Hosp. Clin. Fac. Med.
S. Paulo 57(5):223-228, 2002.
O linfoma primário do fígado é
uma entidade extremamente rara. Os
autores relatam um caso de linfoma
não-Hodgkin de células B grandes
anaplásicas (positivo para CD-20 e
Lambda) em um paciente do sexo mas-
culino de 33 anos. O tumor estava lo-
calizado no lobo hepático direito e foi
tratado por hepatectomia direita ampli-
ada e quimioterapia pós-operatória
com ciclofosfamida, adriamicina,
vincristina e prednisone.
Vinte quatro meses de seguimento
o paciente encontra-se sem recidiva
tumoral.
DESCRITORES: Linfoma hepáti-
co. Cirurgia. Quimioterapia.
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